President Bola Tinubu, at the Federal Executive Council meeting on Wednesday, endorsed three resolutions to tackle the rising cost of pharmaceuticals in the country to avail Nigerians easier access to healthcare.
The council also agreed to implement three “far-reaching decisions” to stem the escalating costs of health devices, such as syringes and needles, and the exit of major manufacturers from the country.
The Coordinating Minister of Health and Social Welfare, Prof. Ali Pate, announced this while briefing State House Correspondents after the first council meeting of 2024, chaired by President Tinubu at the Aso Rock Villa Abuja.
Pate noted that the council had directed the Attorney-General of the Federation to develop executive orders to guarantee the survival of local manufacturers.
He added that specific measures had been implemented to address the rising expenses of pharmaceuticals, provide financial support to health sector regulatory bodies and alleviate the issue of health care professionals leaving the sector, described as the japa wave.
According to Pate, the purpose of the Executive Order is to facilitate the growth of local drug manufacturers and ensure equitable pricing of vital medications.
He explained that this action is deemed necessary due to the departure of prominent global pharmaceutical corporations from Nigeria, resulting in less competition.
To strengthen health care regulation and protect citizens, the minister also revealed that key regulatory bodies, including the Medical and Dental Council, would continue to receive funding, except from cuts impacting other professional associations.
On the shortage of health care workers, Pate said the Council had delegated approval of recruitment waivers to the health ministry directly, explaining that this would accelerate hiring and reduce delays.
